Norwegian hospital begin pilot study with Monsenso


Implementing of the Monsenso mHealth solution aims to reduce hospital readmissions for bipolar patients at Lovisenberg Hopital in Oslo, Norway.

The Norwegian hospital, Lovisenberg Diakonale Sykehus, will begin a pilot study with the Monsenso mHealth solution. Lovisenberg provides specialised health care services in mental health and internal medicine for 180,000 inhabitants of four City Districts in Oslo (inner city), and was signed up as a customer by Computas, Monsenso’s partner in Norway. 

The pilot study, which will include 50 patients suffering from bipolar disorder, aims to reduce hospital readmissions by using the Monsenso mHealth solution to intervene at an early stage. 

- Lovisenberg is committed to finding innovative solutions that help them provide better care to their patients in a more cost-efficient way. With the implementation of the Monsenso mHealth solution, a patient’s historical, aggregated data will be available more easily, says Thomas Lethenborg, CEO at Monsenso.

Lovisenberg would conduct a six-month pilot study to determine if the solution should be widely implemented with other mental illnesses.

- We are thrilled to have signed up our first customer with Monsenso. This type of technology gives new opportunities for the integration of mobile health into the existing mental health services in Norway; and I am confident that once clinicians start experiencing the clinical and financial benefits of implementing the solution, we will sign up more customers in no time!, says Kim Petersen, Executive Director at Computas AS.

The trial would allow Lovisenberg to investigate how a remote patient monitoring solution can be used to improve patient care and patient engagement.

- The Monsenso mHealth solution will help us to access and analyse data in a more efficient way. Besides, since most people carry their smartphones all the time, patients can answer their self-assessments and clinical questionnaires wherever they are, without feeling self-conscious, says Andreas Joner, Head of Clinic at Lovisenberg.

The Monsenso mHealth solution for mental illnesses is based on a triple-loop treatment model that connects patients, carers and clinicians.

Patients use a smartphone to fill in routine self-assessments that reveal their current state of mind and collect sensor data.  The smartphone app also works as a self-help tool that allows patients to manage their symptoms and the behaviours that trigger those symptoms. Carers are also given a smartphone that allows them to assess the overall well-being of the one they care for, and make notes that are shared with the patient and the clinician.

Clinicians use a web portal that provides historical information on each patient, including routine self-assessments and clinical questionnaires. The portal also allows them to obtain an overview of their patients’ illness progression, symptoms, medication compliance, and medical record keeping.

With more than 1300 employees, Lovisenberg Diakonale Sykehus delivers effective treatment and outpatient care across its multiple sites. The hospital provides specialist care in mental health.

For additional information contact:

Jennifer Highland
Marketing and Communications Manager
+45 8171 7713

About Monsenso

Monsenso is an innovative technology company offering an mHealth solution to help optimise the treatment of mental disorders. The mission is to assist healthcare providers, researchers, and individuals in overcoming the burden of mental illness. Monsensos solution provides a detailed overview of a patient’s mental health through the collection of behavioural data and self-monitoring. Based on continued research and development, our team is committed to developing comprehensive solutions that fit seamlessly into the lives of individuals, increasing the quality and efficacy of their treatment.

For more information see www.monsenso.com

Link to source

Monsenso is member of Welfare Tech. 

Supported by

Welfare Tech is funded by the Danish Ministry of Higher Education and Science, The Southern Denmark Growth Forum and The European Regional Development Fund.